SHLPs have varying lengths and effects, but none combine rapid nuclear entry with potent modulation of both energy metabolism and redox defense quite like MOTS-C peptide
Similarly, a recently approved antidiabetic agent of the same drug family, semaglutide, has been assessed in a double-blind phase 2 RCT in 320 patients with NASH without DM2, given subcutaneously once daily, at various doses, for 72 weeks (NCT02970942)
Meanwhile, a number of researchers elsewhere had also begun to uncover evidence pointing to a relationship between hormones produced in the intestine and pancreatic islets
How our clinic supports your journey beyond medication At our clinic, we understand that weight management is a lifelong journey, not a temporary intervention
Are you managing obesity as a chronic disease